CLB
Core Laboratories N.V. NYSE Listed Sep 21, 1995$13.44
Mkt Cap $619.5M
52w Low $9.72
35.0% of range
52w High $20.36
50d MA $16.36
200d MA $15.15
P/E (TTM)
20.7x
EV/EBITDA
14.6x
P/B
2.3x
Debt/Equity
0.7x
ROE
11.2%
P/FCF
33.0x
RSI (14)
—
ATR (14)
—
Beta
1.16
50d MA
$16.36
200d MA
$15.15
Avg Volume
394.4K
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Van Heuven Goedhartlaan 7 B · Amstelveen, TX 1181 LE · NL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 0.06 | 0.06 | +0.0% | 17.30 | -6.8% | -15.3% | -4.0% | -2.1% | +3.3% | -3.9% | — |
| Feb 4, 2026 | AMC | 0.19 | 0.21 | +9.8% | 19.61 | -3.1% | -4.2% | -1.2% | +2.3% | -1.8% | +1.6% | — |
| Oct 22, 2025 | AMC | 0.19 | 0.22 | +15.8% | 12.77 | +18.0% | +28.8% | +2.5% | +0.0% | -2.3% | -2.2% | — |
| Jul 23, 2025 | AMC | 0.18 | 0.19 | +5.6% | 12.62 | +4.9% | +5.9% | -12.2% | +1.9% | -3.1% | -3.8% | — |
| Apr 23, 2025 | AMC | 0.15 | 0.14 | -6.7% | 12.07 | +3.6% | -3.8% | +2.2% | -4.7% | +3.7% | -3.0% | — |
| Jan 29, 2025 | AMC | 0.23 | 0.22 | -4.3% | 18.54 | -6.4% | -4.3% | -4.4% | -2.5% | +4.2% | +3.5% | — |
| Oct 23, 2024 | AMC | 0.23 | 0.25 | +8.7% | 17.08 | +4.4% | +10.9% | +2.6% | -1.3% | +1.7% | -1.1% | — |
| Jul 24, 2024 | AMC | 0.21 | 0.22 | +4.8% | 22.02 | +0.0% | +10.6% | -0.7% | -1.8% | +3.1% | +0.0% | — |
| Apr 24, 2024 | AMC | 0.16 | 0.19 | +18.8% | 16.53 | +7.9% | +3.3% | -0.8% | +0.1% | -6.8% | -0.6% | — |
| Jan 31, 2024 | AMC | 0.20 | 0.19 | -5.0% | 15.77 | +6.0% | -4.7% | -1.3% | +0.6% | +0.1% | -2.2% | — |
| Nov 1, 2023 | AMC | 0.22 | 0.22 | +0.0% | 21.02 | +3.3% | +1.1% | -0.6% | -3.6% | -7.8% | +0.9% | — |
| Jul 26, 2023 | AMC | 0.20 | 0.21 | +5.0% | 24.80 | -0.2% | -0.8% | +6.0% | -0.4% | +5.5% | -5.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 16 | Stifel | Maintains | Hold → Hold | — | $11.68 | $11.47 | -1.8% | -3.1% | +2.9% | -2.1% | +0.2% | +3.1% |
| May 13 | Citigroup | Maintains | Neutral → Neutral | — | $12.06 | $12.03 | -0.2% | +3.3% | -2.2% | -2.5% | -0.2% | -2.0% |
| Apr 15 | Stifel | Maintains | Hold → Hold | — | $12.15 | $12.08 | -0.6% | -1.3% | +2.8% | +2.4% | -2.9% | +1.5% |
| Mar 12 | Citigroup | Upgrade | Sell → Neutral | — | $14.62 | $15.04 | +2.9% | +3.1% | -2.5% | +3.6% | -2.2% | +2.0% |
| Feb 20 | Citigroup | Maintains | Sell → Sell | — | $16.88 | $16.73 | -0.9% | -0.1% | -4.3% | -1.4% | -2.0% | -3.8% |
| Oct 31 | Citigroup | Maintains | Sell → Sell | — | $19.28 | $19.05 | -1.2% | -2.0% | +0.0% | +2.2% | +1.2% | +10.6% |
| May 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $22.51 | $22.13 | -1.7% | -2.1% | -3.4% | +4.3% | -3.4% | +2.0% |
| Apr 28 | Stifel | Maintains | Hold → Hold | — | $22.56 | $22.79 | +1.0% | -0.2% | -2.1% | -3.4% | +4.3% | -3.4% |
| Apr 18 | BofA Securities | Downgrade | Neutral → Underperform | — | $22.31 | $20.83 | -6.6% | -1.4% | -0.6% | -1.6% | -1.1% | +3.4% |
| Feb 7 | Citigroup | Maintains | Neutral → Neutral | — | $25.67 | $26.11 | +1.7% | +2.8% | -0.1% | -2.9% | +1.2% | +0.1% |
| Jan 9 | BofA Securities | Upgrade | Underperform → Neutral | — | $21.02 | $22.01 | +4.7% | +5.1% | +2.7% | +0.1% | +2.5% | +0.4% |
| Oct 7 | Citigroup | Upgrade | Sell → Neutral | — | $16.45 | $16.58 | +0.8% | +1.0% | -3.1% | -1.8% | -2.1% | +8.4% |
| Sep 26 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $13.91 | $13.66 | -1.8% | -4.2% | +2.2% | +5.2% | -1.0% | -5.0% |
| Aug 1 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $18.94 | $18.38 | -3.0% | -4.9% | +2.0% | -6.2% | -5.5% | +0.4% |
| Jul 13 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $16.72 | $16.33 | -2.3% | -0.4% | -7.5% | +3.1% | +5.1% | +5.9% |
| May 2 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $26.00 | $25.78 | -0.8% | -2.0% | -1.5% | +3.9% | -0.2% | +5.5% |
| Apr 18 | Piper Sandler | Downgrade | Neutral → Underweight | — | $33.61 | $32.66 | -2.8% | -0.6% | -3.6% | -4.4% | -3.4% | -2.0% |
| Apr 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $33.62 | $33.36 | -0.8% | -5.3% | +3.1% | +0.6% | +1.8% | -0.6% |
| Jan 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $27.35 | $27.78 | +1.6% | -2.4% | -0.5% | -2.7% | +0.3% | +3.5% |
| Dec 7 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $24.52 | $25.08 | +2.3% | +2.0% | -0.8% | -1.1% | +0.5% | -4.1% |
| Oct 18 | BofA Securities | Downgrade | Neutral → Underperform | — | $31.54 | $30.19 | -4.3% | -4.5% | -1.2% | -0.8% | -4.1% | -0.3% |
| Oct 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $30.29 | $30.83 | +1.8% | -1.4% | +3.4% | +0.4% | +2.3% | -0.5% |
| Aug 3 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $33.07 | $32.57 | -1.5% | -0.3% | -8.2% | +0.6% | -0.4% | -2.6% |
| Jul 9 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $36.11 | $35.97 | -0.4% | +0.2% | +0.4% | +3.0% | -1.8% | -4.6% |
| Jun 14 | Citigroup | Downgrade | Neutral → Sell | — | $47.81 | $46.69 | -2.3% | -4.8% | -0.4% | -0.5% | -5.9% | -2.6% |
| Mar 25 | Morgan Stanley | Maintains | Overweight → Overweight | — | $29.38 | $28.89 | -1.7% | +1.5% | +2.8% | -5.6% | -1.5% | +1.0% |
| Dec 18 | JP Morgan | Downgrade | Neutral → Underweight | — | $25.77 | $25.08 | -2.7% | -3.7% | +0.5% | +1.9% | +4.2% | -1.3% |
| Nov 10 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $18.59 | $19.56 | +5.2% | -2.5% | -0.7% | -2.3% | +4.6% | +12.9% |
| Oct 26 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $15.35 | $15.05 | -2.0% | -1.8% | +0.6% | -7.5% | +1.4% | +1.6% |
| Sep 29 | ABN Amro | Upgrade | Sell → Hold | — | $16.00 | $16.70 | +4.4% | -0.3% | -4.3% | -6.4% | +4.1% | +4.0% |
| Jul 27 | Piper Sandler | Maintains | Neutral → Neutral | — | $23.74 | $23.75 | +0.0% | -1.6% | -3.5% | +1.8% | -3.6% | -3.7% |
| Jul 24 | Stifel | Maintains | Hold → Hold | — | $23.61 | $23.42 | -0.8% | +0.6% | -1.6% | -3.5% | +1.8% | -3.6% |
| Jul 16 | ScotiaBank | Downgrade | Sector Outperform → Perform | — | $21.39 | $20.56 | -3.9% | -3.4% | -1.7% | -0.4% | +10.4% | -0.3% |
| Jul 8 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $21.60 | $21.81 | +1.0% | +2.0% | -8.8% | +3.4% | -2.9% | +4.5% |
| May 19 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $20.59 | $20.35 | -1.2% | -8.0% | +4.7% | -0.8% | -0.3% | +0.6% |
| Apr 24 | Stifel | Maintains | Hold → Hold | — | $14.94 | $15.47 | +3.5% | +0.1% | +3.7% | +9.2% | +16.4% | -0.5% |
| Apr 13 | ScotiaBank | Upgrade | Sector Perform → Sector Outperform | — | $11.67 | $12.40 | +6.3% | +1.5% | +1.2% | -3.5% | -6.6% | +8.7% |
| Apr 7 | Piper Sandler | Maintains | Neutral → Neutral | — | $10.31 | $10.93 | +6.0% | +1.4% | +5.6% | +5.8% | +1.5% | +1.2% |
| Mar 31 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $9.51 | $9.77 | +2.7% | +8.7% | -8.2% | +1.7% | +2.6% | +4.1% |
| Mar 18 | Stifel | Maintains | Hold → Hold | — | $7.99 | $7.48 | -6.4% | +0.8% | +16.6% | +6.0% | -1.5% | +11.3% |
| Mar 17 | JP Morgan | Maintains | Neutral → Neutral | — | $8.16 | $8.12 | -0.5% | -2.1% | +0.8% | +16.6% | +6.0% | -1.5% |
| Mar 16 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.49 | $7.20 | -15.2% | -3.9% | -2.1% | +0.8% | +16.6% | +6.0% |
| Mar 13 | Citigroup | Maintains | Neutral → Neutral | — | $8.06 | $8.55 | +6.1% | +5.3% | -3.9% | -2.1% | +0.8% | +16.6% |
| Mar 10 | Stifel | Maintains | Hold → Hold | — | $13.52 | $15.73 | +16.3% | -3.4% | -16.3% | -26.3% | +5.3% | -3.9% |
| Mar 9 | BofA Securities | Downgrade | Buy → Underperform | — | $23.84 | $16.77 | -29.7% | -43.3% | -3.4% | -16.3% | -26.3% | +5.3% |
| Jan 14 | Bernstein | Maintains | Market Perform → Perform | — | $40.24 | $39.95 | -0.7% | +1.2% | -2.1% | +0.2% | -0.3% | -1.3% |
| Jan 2 | Stifel | Downgrade | Buy → Hold | — | $37.67 | $37.48 | -0.5% | +2.0% | +4.4% | +2.1% | +0.7% | -2.5% |
| Dec 31 | Cowen & Co. | Maintains | Market Perform → Market Perform | — | $47.46 | $39.40 | -17.0% | -20.6% | +2.0% | +4.4% | +2.1% | +0.7% |
| Dec 10 | Citigroup | Maintains | Neutral → Neutral | — | $44.64 | $44.89 | +0.6% | -3.0% | +1.6% | +3.5% | -1.6% | +1.3% |
| Oct 18 | Citigroup | Maintains | Neutral → Neutral | — | $42.07 | $42.07 | +0.0% | -4.0% | +4.1% | +0.6% | +3.5% | +0.9% |
No insider trades available.
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Core Labs is assessing Middle East geopolitical risks' impact on Q1 2026 earnings, suggesting potential revenue disruption from reduced oil demand or operational challenges that could pressure stock performance.
Mar 23
8-K
Unknown — 8-K Filing
Colibri Group discovered tax accounting adjustments during 10-K preparation that may impact reported earnings and cash tax obligations, requiring investor attention to the full magnitude when disclosed.
Mar 17
8-K · 5.03
! Medium
Core Laboratories Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
Core Laboratories changed its fiscal year end, which may affect investor reporting schedules and comparability with prior periods, though the operational impact is likely minimal.
Mar 5
NT 10-K
!!! Very High
Core Laboratories Inc. -- Late Annual Report -- Distress Signal
Core Laboratories requested an extension to file its annual report due to complex multi-jurisdictional tax accounting issues, signaling potential delays in financial statement completion and possible material tax liabilities.
Mar 3
8-K · 7.01
! Medium
Core Laboratories Inc. -- 8-K 7.01: Regulation FD Disclosure
Core Laboratories will distribute $0.01 per share dividend to shareholders on March 9, 2026, maintaining its modest quarterly payout to investors.
Feb 4
Data updated apr 25, 2026 1:33am
· Source: massive.com